← FDA Drug Approvals (Drugs@FDA)
ONAPGO
NDA · New Drug Application · Sponsor: MDD US · Approved 2025-02-03
Drug application
- FDA Application #
NDA214056- Application type
- New Drug Application
- Brand name
- ONAPGO
- Generic name
- APOMORPHINE HYDROCHLORIDE
- Active ingredients
- APOMORPHINE HYDROCHLORIDE
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- MDD US
- Manufacturer
- MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc
- First approval
- 2025-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown